Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article published on 26 July 2017 |
| Author/s |
author: Shuta Tomida Kei Namba Kazunori Tsukuda Hidejiro Torigoe Shinichiro Miyoshi Shinichi Toyooka Junichi Soh Ken Suzawa Hiromasa Yamamoto Kazuhiko Shien |
| Publication date | July 26, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |